Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
This test measures the activity of factor IX, a vitamin K dependent protein that helps your blood form stable clots. It is part of the intrinsic clotting pathway and works with other factors to stop bleeding after an injury.
Laboratories assess factor IX by adding your plasma to a reagent system and observing how well clotting is restored at a standard dilution. The result reflects how effectively factor IX in your sample functions, not just how much of the protein is present.
Doctors use factor IX testing to evaluate unexplained or excessive bleeding, to diagnose or classify hemophilia B, and to look for acquired causes of low factor levels such as liver disease or vitamin K deficiency. It may also be ordered before procedures if you have a bleeding history or a family history of hemophilia.
Your result can guide treatment decisions, including the need for factor replacement therapy, vitamin K, or adjustments to anticoagulant medications. It can also help monitor response to therapy and determine if an inhibitor antibody is interfering with factor IX function.
A lower than expected result suggests reduced factor IX activity. This can be inherited, as in hemophilia B, or acquired from conditions such as vitamin K deficiency, liver dysfunction, or the effect of certain anticoagulant medications. If your result is low, your care team may order additional studies, such as a mixing study or inhibitor testing, to clarify the cause.
A result within the expected range generally means factor IX function is adequate, although your doctor will interpret it alongside other clotting tests and your bleeding history. If you are on anticoagulants or recently had a transfusion or factor infusion, timing and medication details are important for accurate interpretation.
If results do not match how you feel or your bleeding symptoms, you may be asked to repeat testing, adjust medications, or have specialized studies. Your clinician will explain next steps and whether family testing or genetic counseling is appropriate.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Warfarin, some antibiotics that affect vitamin K, and certain direct oral anticoagulants can lower measured factor IX activity or interfere with clotting assays. Always tell the lab and your clinician about all medicines and supplements.
Factor IX is made in the liver and requires vitamin K for proper function. Liver disease or poor vitamin K intake or absorption can reduce activity and may normalize after the underlying issue is treated.
Infusions of factor concentrates or plasma can temporarily raise measured activity. Schedule testing to avoid false reassurance or to document response at the intended post‑infusion time point.
Improper tube fill, difficult draws, delays to the lab, or storage outside recommended conditions can affect clotting assays. Proper citrate tube filling and prompt processing help ensure accurate results.
Some people develop antibodies that block factor IX function or interfere with the assay. When suspected, your doctor may request a mixing study or inhibitor screen to sort out the cause of a low result.
Physiologic changes in pregnancy and acute inflammation can alter some clotting factors and test behavior. Your clinician will interpret results in context and may repeat testing after recovery or postpartum if needed.
References